Skip to main content
Premium Trial:

Request an Annual Quote

Joseph Hill, Mike Bouchard, Gordon Parry

Premium
Metabolix has appointed Joseph Hill to the chief financial officer position. Hill recently was senior VP and CFO at Amicas, and before that he was VP and CFO at both Dirig Software and Maconomy.
 

 
Illumina has appointed Mike Bouchard to be VP of finance. Bouchard had the same title at Websense, and he also has been director of finance at Gateway and global finance manager at Rohm & Haas Company, and CFO at SAL Limited.
 

 
Monogram Biosciences has promoted Gordon Parry to the post of VP of research and development, oncology, from the role of senior director of the same department. Parry was head of cancer research at Berlex Biosciences. He also was a researcher at the University of California’s Lawrence Berkeley Laboratory.

Filed under

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.